Teladoc Health Inc
NYSE:TDOC
Balance Sheet
Balance Sheet Decomposition
Teladoc Health Inc
Current Assets | 1.5B |
Cash & Short-Term Investments | 1.1B |
Receivables | 214.3m |
Other Current Assets | 174m |
Non-Current Assets | 2.8B |
PP&E | 67.1m |
Intangibles | 2.7B |
Other Non-Current Assets | 80m |
Current Liabilities | 388.8m |
Accounts Payable | 37.7m |
Accrued Liabilities | 249.9m |
Other Current Liabilities | 101.2m |
Non-Current Liabilities | 1.6B |
Long-Term Debt | 1.5B |
Other Non-Current Liabilities | 103.5m |
Balance Sheet
Teladoc Health Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
46
|
55
|
50
|
43
|
424
|
514
|
733
|
893
|
918
|
1 124
|
|
Cash Equivalents |
46
|
55
|
50
|
43
|
424
|
514
|
733
|
893
|
918
|
1 124
|
|
Short-Term Investments |
0
|
82
|
16
|
79
|
55
|
3
|
53
|
3
|
0
|
0
|
|
Total Receivables |
7
|
12
|
14
|
27
|
44
|
57
|
169
|
169
|
236
|
230
|
|
Accounts Receivables |
7
|
12
|
14
|
27
|
44
|
57
|
169
|
169
|
211
|
217
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
13
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
56
|
73
|
56
|
30
|
|
Other Current Assets |
1
|
2
|
3
|
7
|
11
|
14
|
47
|
87
|
105
|
106
|
|
Total Current Assets |
54
|
152
|
83
|
156
|
533
|
588
|
1 060
|
1 225
|
1 315
|
1 489
|
|
PP&E Net |
1
|
6
|
7
|
9
|
10
|
37
|
75
|
74
|
71
|
72
|
|
PP&E Gross |
1
|
6
|
7
|
9
|
10
|
37
|
75
|
74
|
71
|
72
|
|
Accumulated Depreciation |
1
|
2
|
4
|
8
|
12
|
16
|
22
|
34
|
48
|
60
|
|
Intangible Assets |
8
|
15
|
25
|
160
|
247
|
225
|
2 021
|
1 910
|
1 837
|
1 678
|
|
Goodwill |
28
|
56
|
188
|
499
|
737
|
746
|
14 581
|
14 504
|
1 073
|
1 073
|
|
Other Long-Term Assets |
0
|
0
|
0
|
1
|
1
|
7
|
18
|
21
|
49
|
80
|
|
Other Assets |
28
|
56
|
188
|
499
|
737
|
746
|
14 581
|
14 504
|
1 073
|
1 073
|
|
Total Assets |
92
N/A
|
230
+150%
|
304
+32%
|
824
+171%
|
1 529
+86%
|
1 603
+5%
|
17 755
+1 008%
|
17 735
0%
|
4 345
-76%
|
4 392
+1%
|
|
Liabilities | |||||||||||
Accounts Payable |
2
|
2
|
2
|
4
|
8
|
9
|
46
|
47
|
48
|
44
|
|
Accrued Liabilities |
6
|
11
|
13
|
27
|
41
|
58
|
156
|
162
|
193
|
239
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
1
|
1
|
2
|
0
|
0
|
0
|
56
|
13
|
11
|
0
|
|
Other Current Liabilities |
1
|
3
|
4
|
9
|
13
|
23
|
75
|
108
|
147
|
138
|
|
Total Current Liabilities |
10
|
18
|
21
|
40
|
62
|
90
|
333
|
331
|
400
|
421
|
|
Long-Term Debt |
25
|
25
|
42
|
207
|
415
|
440
|
1 390
|
1 235
|
1 543
|
1 539
|
|
Deferred Income Tax |
0
|
1
|
2
|
13
|
32
|
22
|
102
|
76
|
51
|
49
|
|
Other Liabilities |
3
|
7
|
8
|
5
|
6
|
37
|
47
|
47
|
44
|
58
|
|
Total Liabilities |
39
N/A
|
51
+31%
|
73
+43%
|
265
+263%
|
516
+95%
|
589
+14%
|
1 871
+218%
|
1 689
-10%
|
2 038
+21%
|
2 066
+1%
|
|
Equity | |||||||||||
Common Stock |
121
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
72
|
131
|
205
|
312
|
409
|
508
|
993
|
1 421
|
15 008
|
15 229
|
|
Additional Paid In Capital |
5
|
309
|
436
|
866
|
1 435
|
1 539
|
16 858
|
17 473
|
17 359
|
17 592
|
|
Other Equity |
0
|
0
|
0
|
4
|
13
|
17
|
19
|
6
|
43
|
37
|
|
Total Equity |
53
N/A
|
179
+238%
|
231
+29%
|
559
+142%
|
1 013
+81%
|
1 014
+0%
|
15 884
+1 466%
|
16 046
+1%
|
2 308
-86%
|
2 326
+1%
|
|
Total Liabilities & Equity |
92
N/A
|
230
+150%
|
304
+32%
|
824
+171%
|
1 529
+86%
|
1 603
+5%
|
17 755
+1 008%
|
17 735
0%
|
4 345
-76%
|
4 392
+1%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
2
|
39
|
46
|
62
|
71
|
73
|
150
|
160
|
163
|
167
|